ANNX
Price
$4.50
Change
+$0.18 (+4.17%)
Updated
Nov 28 closing price
Capitalization
643.92M
100 days until earnings call
Intraday BUY SELL Signals
DNTH
Price
$43.98
Change
-$0.05 (-0.11%)
Updated
Nov 28 closing price
Capitalization
1.89B
Intraday BUY SELL Signals
Interact to see
Advertisement

ANNX vs DNTH

Header iconANNX vs DNTH Comparison
Open Charts ANNX vs DNTHBanner chart's image
Annexon
Price$4.50
Change+$0.18 (+4.17%)
Volume$1.76M
Capitalization643.92M
Dianthus Therapeutics
Price$43.98
Change-$0.05 (-0.11%)
Volume$242.15K
Capitalization1.89B
ANNX vs DNTH Comparison Chart in %
ANNX
Daily Signal:
Gain/Loss:
DNTH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANNX vs. DNTH commentary
Nov 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a StrongBuy and DNTH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 29, 2025
Stock price -- (ANNX: $4.50 vs. DNTH: $43.98)
Brand notoriety: ANNX and DNTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 70% vs. DNTH: 37%
Market capitalization -- ANNX: $643.92M vs. DNTH: $1.89B
ANNX [@Biotechnology] is valued at $643.92M. DNTH’s [@Biotechnology] market capitalization is $1.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileDNTH’s FA Score has 1 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • DNTH’s FA Score: 1 green, 4 red.
According to our system of comparison, DNTH is a better buy in the long-term than ANNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 6 TA indicator(s) are bullish while DNTH’s TA Score has 6 bullish TA indicator(s).

  • ANNX’s TA Score: 6 bullish, 4 bearish.
  • DNTH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ANNX and DNTH are a good buy in the short-term.

Price Growth

ANNX (@Biotechnology) experienced а +5.39% price change this week, while DNTH (@Biotechnology) price change was +6.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Reported Earning Dates

ANNX is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($1.89B) has a higher market cap than ANNX($644M). DNTH YTD gains are higher at: 101.743 vs. ANNX (-12.281). DNTH has higher annual earnings (EBITDA): -129.49M vs. ANNX (-198.44M). DNTH has more cash in the bank: 257M vs. ANNX (227M). DNTH has less debt than ANNX: DNTH (1.33M) vs ANNX (27.6M). DNTH has higher revenues than ANNX: DNTH (4.85M) vs ANNX (0).
ANNXDNTHANNX / DNTH
Capitalization644M1.89B34%
EBITDA-198.44M-129.49M153%
Gain YTD-12.281101.743-12%
P/E RatioN/A3.24-
Revenue04.85M-
Total Cash227M257M88%
Total Debt27.6M1.33M2,075%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
19
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
55
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANNXDNTH
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signal:
Gain/Loss:
DNTH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CGRIX82.410.49
+0.60%
Calamos Growth I
RYROX49.51N/A
N/A
Rydex Russell 2000 C
ESEIX34.95N/A
N/A
Eaton Vance Atlanta Capital Sel Eq I
ACCLX16.34N/A
N/A
American Century Mid Cap Value C
ETLCX15.22N/A
N/A
Eventide Large Cap Focus C